KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Net Cash Flow: 2009-2025

Historic Net Cash Flow for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $115.0 million.

  • Quest Diagnostics' Net Cash Flow fell 76.67% to $115.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$328.0 million, marking a year-over-year decrease of 152.82%. This contributed to the annual value of -$130.0 million for FY2024, which is 135.04% down from last year.
  • Per Quest Diagnostics' latest filing, its Net Cash Flow stood at $115.0 million for Q3 2025, which was down 9.45% from $127.0 million recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Net Cash Flow ranged from a high of $543.0 million in Q4 2023 and a low of -$670.0 million during Q2 2021.
  • Its 3-year average for Net Cash Flow is $11.0 million, with a median of -$49.0 million in 2023.
  • Its Net Cash Flow has fluctuated over the past 5 years, first crashed by 322.22% in 2022, then skyrocketed by 2,800.00% in 2024.
  • Over the past 5 years, Quest Diagnostics' Net Cash Flow (Quarterly) stood at -$115.0 million in 2021, then tumbled by 234.78% to -$385.0 million in 2022, then skyrocketed by 241.04% to $543.0 million in 2023, then tumbled by 138.31% to -$208.0 million in 2024, then crashed by 76.67% to $115.0 million in 2025.
  • Its last three reported values are $115.0 million in Q3 2025, $127.0 million for Q2 2025, and -$362.0 million during Q1 2025.